The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?

Transactions of the American Clinical and Climatological Association

Volumn 124, Issue , 2013, Pages 46-60

  Shayman, James A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; DIOXANE DERIVATIVE; ELIGLUSTAT; GLUCOSYLTRANSFERASE; GLYCOSPHINGOLIPID; PYRROLIDINE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG DESIGN; GAUCHER DISEASE; HUMAN;

DIOXANES; DRUG DESIGN; GAUCHER DISEASE; GLUCOSYLTRANSFERASES; GLYCOSPHINGOLIPIDS; HUMANS; PYRROLIDINES;

EID: 84895855941     PISSN: 00657778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)